4YX0 Stock Chart & Stats
€0.01
€0.00(0.00%)
At close: 4:00 PM EDT
€0.01
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.03
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.16K
Market Cap
€7.84M
Enterprise Value€7.93M
Total Cash (Recent Filing)€9.05M
Total Debt (Recent Filing)€286.64K
Price to Earnings (P/E)―
Beta-0.55
Next Earnings
Dec 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding614,124,760
10 Day Avg. Volume0
30 Day Avg. Volume1,155
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)0.87
Price to Sales (P/S)2.48
P/FCF Ratio-4.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low debt reduces fixed financial obligations and limits interest-related pressure on a still-loss-making business. This gives management greater flexibility to direct available resources toward operations and product development, while lowering the balance-sheet risk associated with future volatility.
Revenue Scale-UpThe substantial increase in revenue from the company’s early base indicates that its legal psilocybin product model has achieved meaningful commercial traction. A larger operating base can support broader distribution, stronger brand awareness, and improved leverage if sales growth becomes more consistent.
Positive Gross ProfitPositive gross profit demonstrates that product sales generate economic value before operating expenses, while the improvement from earlier margin levels suggests some progress in the underlying commercial model. Further scale could allow this gross profit base to absorb overhead more effectively over time.
Bears Say
Persistent LossesLarge operating and net losses remain the company’s central fundamental weakness because revenue and gross profit are not yet sufficient to cover the cost structure. Continued losses can restrict reinvestment capacity, increase reliance on external capital, and delay the achievement of sustainable earnings.
Negative Cash GenerationRecurring negative operating and free cash flow show that the business is not yet self-funding, even after some earlier improvement in cash burn. Persistent cash consumption can reduce financial flexibility and force management to prioritize funding needs over expansion, potentially increasing dilution risk.
Uneven Revenue TrendThe recent revenue decline indicates that commercial momentum is not yet dependable, despite the longer-term increase from a small historical base. An uneven sales trajectory makes operating leverage harder to realize, complicates planning, and leaves profitability vulnerable to further weakness in demand.
Red Light Holland News
4YX0 FAQ
What was Red Light Holland’s price range in the past 12 months?
Red Light Holland lowest stock price was <€0.01 and its highest was €0.03 in the past 12 months.
What is Red Light Holland’s market cap?
Red Light Holland’s market cap is €7.84M.
When is Red Light Holland’s upcoming earnings report date?
Red Light Holland’s upcoming earnings report date is Dec 02, 2026 which is in 31 days.
How were Red Light Holland’s earnings last quarter?
Red Light Holland released its earnings results on Jul 29, 2026. The company reported -€0.002 earnings per share for the quarter.
Is Red Light Holland overvalued?
According to Wall Street analysts Red Light Holland’s price is currently Overvalued.
Does Red Light Holland pay dividends?
Red Light Holland does not currently pay dividends.
What is Red Light Holland’s EPS estimate?
Red Light Holland’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Red Light Holland have?
Red Light Holland has 614,124,760 shares outstanding.
What happened to Red Light Holland’s price movement after its last earnings report?
Red Light Holland reported an EPS of -€0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Red Light Holland?
Currently, no hedge funds are holding shares in DE:4YX0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Red Light Holland
Based in Toronto, Ontario, Red Light Holland Corp. is primarily involved in the cultivation, production, and retail of recreational magic truffles for the Dutch market. Beyond its own cultivated offerings, the company also engages in the sourcing, distribution, and international export of various truffle varieties. Its diverse product portfolio further extends to include cannabidiol (CBD) products, cannabis seeds, headshop essentials, and a selection of cannabis-infused baked goods like muffins, cookies, and cakes. These items are marketed under the iMicrodose and Maka brands and are available to consumers through 74 brick-and-mortar SmartShops, the iMicrodose.nl website, and several other online retail platforms throughout the Netherlands.
Technical Analysis
Good Shroom Co Inc
―
Revive Therapeutics
―
Charlotte's Web Holdings
―
Curaleaf Holdings
―
Planet 13 Holdings
―